273 related articles for article (PubMed ID: 16941589)
1. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
Yoon JJ; Chung HJ; Lee HJ; Park TG
J Biomed Mater Res A; 2006 Dec; 79(4):934-42. PubMed ID: 16941589
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
[TBL] [Abstract][Full Text] [Related]
3. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
Yoon JJ; Chung HJ; Park TG
J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
[TBL] [Abstract][Full Text] [Related]
4. Cell affinity for bFGF immobilized heparin-containing poly(lactide-co-glycolide) scaffolds.
Shen H; Hu X; Yang F; Bei J; Wang S
Biomaterials; 2011 May; 32(13):3404-12. PubMed ID: 21296407
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
6. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis.
Sung HJ; Meredith C; Johnson C; Galis ZS
Biomaterials; 2004 Nov; 25(26):5735-42. PubMed ID: 15147819
[TBL] [Abstract][Full Text] [Related]
7. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid modified biodegradable scaffolds for cartilage tissue engineering.
Yoo HS; Lee EA; Yoon JJ; Park TG
Biomaterials; 2005 May; 26(14):1925-33. PubMed ID: 15576166
[TBL] [Abstract][Full Text] [Related]
9. Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis.
Kim MS; Bhang SH; Yang HS; Rim NG; Jun I; Kim SI; Kim BS; Shin H
Tissue Eng Part A; 2010 Oct; 16(10):2999-3010. PubMed ID: 20486788
[TBL] [Abstract][Full Text] [Related]
10. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery.
Chung HJ; Kim HK; Yoon JJ; Park TG
Pharm Res; 2006 Aug; 23(8):1835-41. PubMed ID: 16858650
[TBL] [Abstract][Full Text] [Related]
11. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
12. Release kinetics and in vitro bioactivity of basic fibroblast growth factor: effect of the thickness of fibrous matrices.
Kim MS; Shin YM; Lee JH; Kim SI; Nam YS; Shin CS; Shin H
Macromol Biosci; 2011 Jan; 11(1):122-30. PubMed ID: 20886548
[TBL] [Abstract][Full Text] [Related]
13. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
[TBL] [Abstract][Full Text] [Related]
14. Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering.
Somers P; Narine K; De Somer F; de Vos F; V Nooten G
Growth Factors; 2008 Oct; 26(5):293-9. PubMed ID: 18651289
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
Nie H; Wang CH
J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
[TBL] [Abstract][Full Text] [Related]
16. In vitro release of dexamethasone or bFGF from chitosan/hydroxyapatite scaffolds.
Tiğli RS; Akman AC; Gümüşderelioğlu M; Nohutçu RM
J Biomater Sci Polym Ed; 2009; 20(13):1899-914. PubMed ID: 19793446
[TBL] [Abstract][Full Text] [Related]
17. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
18. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.
Nillesen ST; Geutjes PJ; Wismans R; Schalkwijk J; Daamen WF; van Kuppevelt TH
Biomaterials; 2007 Feb; 28(6):1123-31. PubMed ID: 17113636
[TBL] [Abstract][Full Text] [Related]
19. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.
Fu YC; Nie H; Ho ML; Wang CK; Wang CH
Biotechnol Bioeng; 2008 Mar; 99(4):996-1006. PubMed ID: 17879301
[TBL] [Abstract][Full Text] [Related]
20. [Constructing a small-diameter decellularized vascular graft pre-loaded with bFGF].
Zhou M; Liu C; Wei Z; Liu Z; Jiang X; Qiao T; Ran F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):370-5. PubMed ID: 18396724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
